The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases

@article{Casini2014TheS,
  title={The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases},
  author={Giovanni Casini and Massimo Dal Monte and Irene Fornaciari and Luca Filippi and Paola Bagnoli},
  journal={Progress in Retinal and Eye Research},
  year={2014},
  volume={42},
  pages={103-129}
}
Retinal neovascular pathologies, such as diabetic retinopathy, retinopathy of prematurity (ROP) and age-related macular degeneration, may be treated with intravitreal injections of drugs targeting vascular endothelial growth factor (VEGF), the main inducer of neoangiogenesis; however further improvements and alternative strategies are needed. In the last few years, an intense research activity has focused on the β-adrenergic system. The results indicate that, in different experimental models, a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…